Gabelli Downgrades AngioDynamics (ANGO) to Sell; CEO Change and Weak Q4 Results
Get Alerts ANGO Hot Sheet
Price: $15.86 --0%
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 7 | New: 22
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 7 | New: 22
Join SI Premium – FREE
Gabelli downgraded AngioDynamics (NASDAQ: ANGO) from Hold to Sell.
Gabelli analyst says, "There is simply too much uncertainty with the CEO transition, the impending loss of the LC bead distribution agreement (13% of sales), and potential acquisitions. Quarterly results remain erratic and the development of the IRE technology remains a multiyear project. These challenges more than offset a reasonable 6x EBITDA valuation and $5.00 per share in net cash."
For more ratings news on AngioDynamics click here and for the rating history of AngioDynamics click here.
Shares of AngioDynamics closed at $14.57 yesterday.
Gabelli analyst says, "There is simply too much uncertainty with the CEO transition, the impending loss of the LC bead distribution agreement (13% of sales), and potential acquisitions. Quarterly results remain erratic and the development of the IRE technology remains a multiyear project. These challenges more than offset a reasonable 6x EBITDA valuation and $5.00 per share in net cash."
For more ratings news on AngioDynamics click here and for the rating history of AngioDynamics click here.
Shares of AngioDynamics closed at $14.57 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Barclays Plc (BARC:LN) (BCS) to Equalweight
- Goldman Sachs Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral
- Berenberg Downgrades DDC Plc. (DCC:LN) (DCCPF) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share